Yellow Fever

GloPID-R mobilized its members to discuss the Yellow Fever outbreak in Angola and several other African countries where there was a risk of a temporary shortage of available vaccines. It developed a working group that evaluating the effectiveness of fractional dosing.

Yellow Fever Working Group

  • Chair: Josie Golding, Wellcome Trust, UK
  • Philip Bejon, Wellcome Trust, UK
  • Moses Bockaire, European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Rafael de Andres Medina, Instituto de Salud Carlos III, Spain
  • Jean-François Delfraissy, Institut National de la Santé et de la Recherche Médicale (INSERM), France
  • Evelyn Depoortere, European Commission
  • Gary Disbrow, US Department of Health and Human Services, USA
  • Joachim Hombach, World Health Organization (WHO)
  • Michael Kurilla, National Institutes of Health (NIH), USA
  • Philip Lambach, World Health Organization (WHO)
  • Chris Lewis, UK Department for International Development (DFID), UK
  • Tina Lorenson, Bill & Melinda Gates Foundation (BMGF), USA
  • Nicole Lurie, US Department of Health and Human, USA
  • Line Matthiessen, European Commission
  • Bernadette Murge, World Health Organization (WHO)
  • Juan Riese, Instituto de Salud Carlos III, Spain
  • Cathy Roth, UK Department for International Development (DFID), UK
  • Erin Staples, Centers for Disease Control and Prevention (CDC), USA
  • Yazdan Yazdanpanah, Institut National de la Santé et de la Recherche Médicale (INSERM), France